News

The chronic kidney disease (CKD) anemia market across the seven major markets (7MM) is forecast to grow at a compound annual ...
The US Food and Drug Administration (FDA) has granted accelerated approval for Regeneron Pharmaceuticals’ Lynozyfic ...